autologous FL-33 CAR T therapy
BJGBYY-IIT-LCYJ-2024-004
Phase 1 small_molecule active
Quick answer
autologous FL-33 CAR T therapy for Refractory/Relapsed Acute Myeloid Leukaemia is a Phase 1 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Refractory/Relapsed Acute Myeloid Leukaemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active